News

The New Republic16hOpinion
An Anti-Science MAHA Extremist Is Playing a Major Role at the FDA
On first glance, Dr. Vinay Prasad’s medical credentials sound impressive. But look closer and you’ll find a narcissistic ...
Vaccines Face Uncertain Approval, Reviews With New FDA Official
The appointment of a vocal critic of expedited approvals of vaccines, Vinay Prasad, to run the FDA’s office responsible for ...
Lisa Jarvis: FDA appointee is a drug critic with a lot to prove
The gravity of these decisions calls for a degree of humility on the part of an FDA leader. And that’s the rub with Vinay ...
FDA to issue new vaccine framework within weeks
FDA to release new guidance soon, clarifying its regulatory framework related to vaccines, particularly COVID-19 shots. Read ...
Fierce Biotech4d
Martin Makary outlines AI plans and the broader vision for his term as FDA commissioner
WASHINGTON, D.C.—FDA Commissioner Martin Makary, M.D., offered more details into the agency’s recently announced plans to ...
STAT4d
Vinay Prasad tapped to run FDA center that regulates vaccines, gene therapies
Vinay Prasad will be the next director of the FDA's Center for Biologics Evaluation and Research, after Peter Marks was forced out.
Stockhead5d
Biocurious: With its ‘molecular Lego’ approach, Arovella is building hope for cancer patients one brick at a time
Inspired by the world's great Lego Masters, Arovella is taking a brick-by-brick approach to building its unique cancer immunotherapy program.
BioSpace5d
Trump’s Drug Pricing Policy, Prasad’s CBER Nod, Bayer’s Layoffs and Galapagos’ Next Chapter
President Donald Trump unwrapped a massive drug pricing policy as CMS prepares for the next round of Medicare drug price ...
FDA Appointee Is a Drug Critic With a Lot to Prove
Vinay Prasad oversees vaccines, gene therapies and the blood supply. His views raise alarms for pharmaceutical companies and ...
www.hks.harvard.edu7d
Center for International Development
The Harvard Center for International Development (CID) is a research center working across the University and a global network of researchers and practitioners to build an international pool of talent ...
New FDA Leadership Could Raise The Bar For Drug Approvals
A former critic of FDA and Pharma will now oversee the regulation of costly and complicated biologics like vaccines, gene therapies, and blood supply.